Identifying Tissue- and Cohort-Specific RNA Regulatory Modules in Cancer Cells Using Multitask Learning

Milad Mokhtaridoost1,2, Philipp G Maass1,3, Mehmet Gönen4,5

  • 1Genetics & Genome Biology Program, The Hospital for Sick Children, Toronto, ON M5G 1X8, Canada.

Cancers
|October 14, 2022
PubMed

Insights

This study introduces a new computational method, MSRFR, to identify crucial microRNA-messenger RNA regulatory modules in tumors. This approach aids in understanding cancer heterogeneity and advancing precision medicine for targeted therapies.

Area of Science:

  • Genomics
  • Bioinformatics
  • Cancer Biology

Background:

  • MicroRNA (miRNA) alterations are key drivers in human cancer development and progression.
  • miRNAs regulate gene expression by interacting with messenger RNAs (mRNAs).
  • Understanding miRNA-mRNA interactions is vital for deciphering tumor heterogeneity and enabling precise cancer diagnosis and treatment.

Purpose of the Study:

  • To develop a novel computational method for identifying tissue- and cohort-specific miRNA-mRNA regulatory modules.
  • To analyze expression profiles of tumor tissues to uncover these regulatory relationships.
  • To support precision medicine by defining tumor-specific molecular signatures.

Main Methods:

  • A multitask learning sparse regularized factor regression (MSRFR) method was established.
  • MSRFR simultaneously models sparse miRNA-mRNA relationships and extracts tissue- and cohort-specific modules.
  • The model was validated on multiple cancer cohorts from different tissues (blood, kidney, lung).

Main Results:

  • MSRFR effectively identifies cancer-related miRNAs within cohort-specific modules.
  • The method successfully distinguishes between tissue-specific and cohort-specific regulatory modules.
  • Tissue-specific information was extracted from diverse cancer cohorts, highlighting MSRFR's versatility.

Conclusions:

  • The MSRFR model accurately determines miRNA-mRNA regulatory modules specific to cancer type and tissue.
  • This approach enhances the understanding of tumor biology and heterogeneity.
  • MSRFR provides a valuable tool for precision medicine, enabling the definition of tumor-specific miRNA-mRNA signatures for improved diagnostics and therapeutics.

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.8K
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.6K
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

4.7K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.5K